Inactive

Requirement to perform requested COVID19 modeling and prediction analyses within a specified time-period; including re-analyses as requested by WRAIR investigators. Such analyses will pertain to US mi... Requirement to perform requested COVID19 modeling and prediction analyses within a specified time-period; including re-analyses as requested by WRAIR investigators. Such analyses will pertain to US military force health protection (FHP) throughout the COCOMS, and will leverage data inputs, assumptions and parameters specified by WRAIR investigators. These analyses will cover a range of FHP-relevant questions which will arise on-demand, and may include healthcare system predictions, epidemic spread predictions, clinical outcome predictions, resource allocation, and the impact of a range of non-pharmaceutical and pharmaceutical interventions.

Inactive

The WRAIR aims to conduct biomedical research that is responsive to Department of Defense and US Army requirements and delivers life-saving products including knowledge, technology and medical materia... The WRAIR aims to conduct biomedical research that is responsive to Department of Defense and US Army requirements and delivers life-saving products including knowledge, technology and medical material that sustain the combat effectiveness of the Warfighter. The purpose of this urgent requirement is to facilitate collaboration between a partnered research laboratory and WRAIR investigators, to perform requested COVID-19 modeling and prediction analyses within a specified time-period; including re-analyses as requested by WRAIR investigators. Such analyses will pertain to US military force health protection (FHP) throughout the COCOMS, and will leverage data inputs, assumptions and parameters specified by WRAIR investigators. These analyses will cover a range of FHP-relevant questions which will arise on-demand, and may include healthcare system predictions, epidemic spread predictions, clinical outcome predictions, resource allocation, and the impact of a range of non-pharmaceutical and pharmaceutical interventions. The contracted partner must have current capacity to provide immediate support, and capabilities to include the following: substantive publication-proven experience in prior epidemic virus forecasting and modeling, a history of publications of substantive modeling analyses specifically for COVID-19, extensive expertise in developing and implementing agent-based models which use notional/synthetic populations and have experience in applying modeling for advanced vaccine development is also a key capability.